The global surgical sutures market size is estimated to reach USD 7.41 billion by 2033, registering a CAGR of 16.34% from 2026 to 2033, according to a new report by Grand View Research, Inc. Rise in surgical procedures due to an increasing number of cardiac diseases is predicted to foster the market growth. These cardiac diseases occur due to the increasing geriatric population and rising number of heart ailments. For instance, according to a WHO report, cardiovascular diseases (CVDs) are the leading cause of death globally; it takes around 17.9 million lives each year.
Lifestyle changes, growing healthcare expenditure, favorable reimbursement scenarios, and government support to improve the healthcare infrastructure are significant factors contributing to the growth of the market. Although the market may have experienced a certain lag in revenue during the pandemic, it is recovering at a decent pace. It is expected to grow considerably during the forecast period. The lockdowns and changes in healthcare priorities have affected the market's demand. The restrictions also affected the supply chain with limited manufacturing activities and travel restrictions, which disrupted the supply of raw materials and the final product.
Key market players are focusing on developing advanced surgical sutures to enhance their market position. For instance, in September 2023, Genesis MedTech obtained approval from China's NMPA for the market release of its absorbable sutures with antibacterial protection, designed to enhance healing and reduce infection risk. This has led to increasing investment in R&D activities by market leaders, further expected to benefit the market in the future.
Request a free sample copy or view report summary: Surgical Sutures Market Report
Based on type, the absorbable segment dominated the market in 2025 and is expected to record the fastest CAGR over the forecast period, due to their ability to temporarily support wounds until they heal and withstand normal stress.
Based on filament, the multifilament segment accounted for the largest market share in 2025, attributed to the advantages associated with multifilament, such as better compliance, high tensile strength, and flexibility.
Based on application, the general surgery segment held the largest share of the market in 2025, driven by the widespread use of surgical sutures as therapeutic agents to prevent and treat thromboembolic disorders.
North America surgical sutures market dominated the global industry with a revenue share of 44.06% in 2025, owing to the strong presence of major local and international companies, which led to the development of innovative products and extensive distribution networks.
Grand View Research has segmented the global surgical sutures market based on type, filament, application, and region:
Surgical Sutures Type Outlook (Revenue, USD Million, 2021 - 2033)
Absorbable
Non-absorbable
Surgical Sutures Filament Outlook (Revenue, USD Million, 2021 - 2033)
Monofilament
Multifilament
Surgical Sutures Application Outlook (Revenue, USD Million, 2021 - 2033)
General Surgery
Ophthalmic Surgery
Cardiovascular Surgery
Orthopedic Surgery
Neurological Surgery
Others
Surgical Sutures Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Sweden
Denmark
Norway
Asia Pacific
China
India
Japan
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Surgical Sutures Market
Medtronic
Stryker
Smith+Nephew
Ethicon (Johnson & Johnson)
B. Braun SE
Riverpoint Medical
Dynarex Corporation
Healthium Medtech Ltd
Lotus Surgicals Pvt Ltd (TI Medical, a Murugappa Group company)
DemeTECH Corporation
Corza Medical
Advanced Medical Solutions Group plc
Meril
"The quality of research they have done for us has been excellent..."